Veerhealth Care Ltd.
Snapshot View

View in App

Prices View details >>

27.40 -1.40 ▼-4.9%

30 January 2023, 04:01:00 PM
Volume: 8,256

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.veerhealthcare.net
Market Cap 19.00 Cr.
Enterprise Value(EV) 18.54 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.08 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 351.85 Trailing Twelve Months Ending 2022-09
Industry PE 32.78 Trailing Twelve Months Ending 2022-09
Book Value / Share 20.45 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.34 Calculated using Price: 27.40
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.69 Cr. 6,934,238 Shares
FaceValue 10
Company Profile
The company is engaged mainly in business of trading and investing in shares and securities.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.86%
1 Week
-1.44%
1 Month
+18.36%
3 Month
+85.14%
6 Month
+149.09%
1 Year
+107.58%
2 Year
+201.10%
5 Year
+64.07%
10 Year
+25.11%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 0.20 0.45 0.07 0.18 1.06 1.20 2.35 2.73 -0.53
Return on Capital Employed (%) 0.31 1.62 1.13 1.00 2.38 2.89 5.50 4.97 2.17
Return on Assets (%) 0.19 0.42 0.06 0.17 0.99 1.02 1.86 2.07 -0.38

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 13 13 13 13 13 13 14 14 14 14
Non Curr. Liab. 0 1 1 1 0 0 3 3 4 4
Curr. Liab. 0 1 1 0 1 3 1 2 2 2
Minority Int.
Equity & Liab. 13 14 14 13 15 16 18 19 20 20
Non Curr. Assets 8 6 7 5 8 13 12 12 14 14
Curr. Assets 5 8 7 8 7 3 6 7 6 6
Misc. Exp. not W/O 0 0
Total Assets 13 14 14 13 15 16 18 19 20 20

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 3 1 2 2 5 6 12 11 10 11
Other Income 1 0 0 1 1 0 0 1 2 2
Total Income 4 2 3 3 6 6 12 12 11 13
Total Expenditure -3 -1 -2 -2 -5 -6 -11 -11 -10 -12
PBIDT 0 0 0 0 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 1 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -7 4 -4 2 2 2 0 1 2
Cash Fr. Inv. 8 -4 4 0 0 -3 -2 -2 0 -1
Cash Fr. Finan. -1 1 0 2 -1 0
Net Change 0 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 41.25 41.92 41.92 41.93 41.93 42.34 44.31 44.36 44.36
Public 58.75 58.08 58.08 58.07 58.07 57.66 55.69 55.64 55.64
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 16 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 we are hereby submitting the certificate received from M/s. Purva Sharegistry (India) Pvt. Ltd. the Registrar and Share Transfer Agent of the Company for the quarter ended 31st December 2022.
Wed, 11 Jan 2023
Voting Results Of Resolutions Passed At The Extra Ordinary General Meeting Of The Company
In terms of Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are submitting herewith the details regarding the voting results of the business transacted at the Extra Ordinary General Meeting of the Company.Further we are also enclosing the Consolidated Report of the Scrutinizer of e-voting and voting at the Extra Ordinary General Meeting of the Company.Please take note that all resolutions are passed with requisite majority.
Tue, 10 Jan 2023
Proceedings Of Extra Ordinary General Meeting Held On 10Th January 2023
This is to inform that Extra Ordinary General Meeting of the Members of the Company was held today i.e. on Tuesday 10th January 2023 at 10.30 A.M. at 6 New Nandu Industrial Estate Mahakali Caves Road Andheri (E) Mumbai - 400 093 to transact the following special business:1. Increase in Authorized Share Capital of the Company and Alteration in Capital Clause of Memorandum of Association of the Company.2. Preferential Issue of Shares.The Chairman announced that the consolidated scrutinizers report shall be placed on the website of the Company and website of NSDL and the same shall simultaneously be informed to the Stock Exchange.The results of voting as per regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 along with consolidated scrutinizers report will be intimated to you separately.

Technical Scans View Details >>

Mon, 30 Jan 2023
High Delivery Percentage High Delivery Percentage
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Month High Close Above Last Month High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 252,338.06 1,051.70 +0.8%
Divi's Laboratories Ltd. 89,367.34 3,366.40 -0.6%
Cipla Ltd. 83,741.18 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. 72,084.75 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. 61,094.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. 52,291.51 1,545.05 +0.5%
Abbott India Ltd. 44,555.01 20,967.75 -1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 61.43 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 29.89 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 31.74 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.79 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.76 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.93 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 50.53 20,967.75 -1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.75 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 3.69 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.28 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.21 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 16.41 20,967.75 -1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 0.00 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,967.75 -1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 798.70 20,967.75 -1.2%

FAQ's On Veerhealth Care Ltd.

What is Veerhealth Care share price?
Can I buy Veerhealth Care shares now?
What is the Market Cap of Veerhealth Care?
What are the key metrics to analyse Veerhealth Care?
What is the 52 Week High and Low of Veerhealth Care?
What is the trend of Veerhealth Care share price?